We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$6.72B
AUM Growth
+$2.09B
Cap. Flow
+$1.43B
Cap. Flow %
21.25%
Top 10 Hldgs %
32.49%
Holding
567
New
175
Increased
115
Reduced
87
Closed
155
Avg Time Held Equity + Options
2.2 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
2.2 quarters
Avg Time Held Equity only
2.3 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
2.2 quarters

Sector Composition

Rank Sector Weight
1 Consumer Staples 24.22%
2 Miscellaneous 13.28%
3 Communication Services 11.75%
4 Consumer Discretionary 11.42%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XOM icon
476
ExxonMobil
XOM
$695B
– –
-210,238
Closed -$19.7M –
XOP icon
477
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.96B
– –
-15,375
Closed -$27K –
YELP icon
478
Yelp
YELP
$1.01B
– –
-62,500
Closed -$1.9M –
TEN icon
479
Tsakos Energy Navigation Ltd
TEN
$1.55B
– –
-20,000
Closed -$469K –
NVRO icon
480
DELISTED
NEVRO CORP.
NVRO
– –
-16,800
Closed -$1.24M –
SWN icon
481
DELISTED
Southwestern Energy Company
SWN
– –
-1,546,353
Closed -$19.5M –
GOL icon
482
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
– –
-433,005
Closed -$917K –
ICPT
483
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-14,919
Closed -$2.13M –
PRTK
484
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-40,000
Closed -$556K –
ISEE
485
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-20,000
Closed -$1.02M –
OTIC
486
DELISTED
Otonomy, Inc.
OTIC
– –
-40,000
Closed -$635K –
GBT
487
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-50,000
Closed -$830K –
SREV
488
DELISTED
ServiceSource International, Inc.
SREV
– –
-621,328
Closed -$2.5M –
XENT
489
DELISTED
Intersect ENT, Inc
XENT
– –
-70,000
Closed -$905K –
FLXN icon
490
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-75,000
Closed -$1.12M –
STAY
491
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
– –
-267,250
Closed -$4M –
OXFD
492
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-50,705
Closed -$456K –
GPOR icon
493
DELISTED
Gulfport Energy Corp.
GPOR
– –
-18,626
Closed -$582K –
ZAYO
494
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-173,000
Closed -$4.83M –
DERM icon
495
DELISTED
Dermira, Inc.
DERM
– –
-55,443
Closed -$1.62M –
GNMX icon
496
DELISTED
Aevi Genomic Medicine Inc
GNMX
– –
-50,000
Closed -$278K –
ONCE
497
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-20,000
Closed -$1.02M –
ALDR
498
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-55,000
Closed -$1.37M –
WP
499
DELISTED
Worldpay, Inc.
WP
– –
-75,901
Closed -$4.3M –
WFT
500
CALL
DELISTED
Weatherford International plc
WFT
– –
-375,000
Closed -$8K –

Similar funds

UBS O'Connor's Q3 2016 Portfolio in Review

As of Q3 2016, UBS O'Connor held 567 positions worth $6.72B, up 45% from $4.64B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

UBS O'Connor deployed $1.43B of net new capital in Q3 2016, opening 175 new positions and adding to 115 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 4,425,977 shares worth $166M.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 14% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Kellanova, an estimated $28M trimmed.

  • UBS O'Connor's largest Q3 2016 buy was iShares MSCI Emerging Markets ETF: 4,425,977 shares worth $166M.
  • UBS O'Connor added most to Procter & Gamble in Q3 2016, an estimated $693M increase.
  • UBS O'Connor's biggest Q3 2016 reduction was Kellanova, cutting an estimated $28M.
  • UBS O'Connor fully exited EMC CORPORATION in Q3 2016, selling an estimated $218M.
  • UBS O'Connor's ten largest holdings make up 32% of its $6.72B portfolio in Q3 2016.
  • UBS O'Connor opened 175 new positions and closed 155 in Q3 2016.
  • UBS O'Connor's portfolio value rose 45% quarter-over-quarter to $6.72B.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.